Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVSEF) Inventory Average (2016 - 2025)

Historic Inventory Average for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $6.3 billion.

  • Novartis Ag's Inventory Average rose 881.5% to $6.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.3 billion, marking a year-over-year increase of 881.5%. This contributed to the annual value of $6.0 billion for FY2025, which is 305.95% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Inventory Average is $6.3 billion, which was up 881.5% from $6.4 billion recorded in Q3 2025.
  • Novartis Ag's Inventory Average's 5-year high stood at $8.1 billion during Q2 2023, with a 5-year trough of $5.7 billion in Q2 2024.
  • Moreover, its 5-year median value for Inventory Average was $6.8 billion (2021), whereas its average is $6.6 billion.
  • As far as peak fluctuations go, Novartis Ag's Inventory Average surged by 13290.47% in 2021, and later crashed by 2869.55% in 2024.
  • Novartis Ag's Inventory Average (Quarter) stood at $6.8 billion in 2021, then grew by 2.97% to $7.0 billion in 2022, then decreased by 17.42% to $5.8 billion in 2023, then grew by 1.21% to $5.8 billion in 2024, then increased by 8.81% to $6.3 billion in 2025.
  • Its last three reported values are $6.3 billion in Q4 2025, $6.4 billion for Q3 2025, and $6.1 billion during Q2 2025.